Quidel | QDEL - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 5.86B 675M 2026-03
Agilent USD 990M 44M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Bruker USD 379.8M 69.4M 2026-03
Cerus USD 33.33M 8.66M 2024-12
Charles River Laboratories USD 279.32M 7.36M 2026-03
Danaher USD 3.59B 375M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Illumina USD 721M 38M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Merit Medical Systems USD 184.8M 10.56M 2026-03
Mettler Toledo International USD 675.44M 65.98M 2025-12
Myriad Genetics USD 146.8M 3M 2025-12
Neogen USD 99M 7.7M 2025-12
OraSure Technologies USD 11.34M 435K 2025-12
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Quidel USD -91.8M 366.6M 2026-03
Revvity USD 387.66M 34M 2026-03
STAAR Surgical USD 43.74M 34.13M 2025-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Waters USD 542M 15.42M 2026-03